You are here

Global

The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.

Wed, 2020-11-18 13:48 — mike kraft

The promising news that not just one but two coronavirus vaccines were more than 90 percent effective in early results has buoyed hopes that an end to the pandemic is in sight.

But even if the vaccines are authorized soon by federal regulators — the companies developing them have said they expect to apply soon — only a sliver of the American public will be able to get one by the end of the year. The two companies, Pfizer and Moderna, have estimated they will have 45 million doses, or enough to vaccinate 22.5 million Americans, by January.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about The Vaccines Will Probably Work. Making Them Fast Will Be the Hard Part.
Log in or register to post comments

Pharma trade group issues guidelines for improving diversity of clinical trial participants

Wed, 2020-11-18 10:14 — mike kraft

PhRMA issues guidelines for improving clinical trial diversity - STAT PhRMA released guidelines on Tuesday to enhance racial and ethnic diversity among participants in clinical trials. Nicholas St. Fleur STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pharma trade group issues guidelines for improving diversity of clinical trial participants
Log in or register to post comments

FDA authorizes 1st rapid virus test that gives results at home

Wed, 2020-11-18 09:07 — mike kraft

FDA allows 1st rapid virus test that gives results at home WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes. The... AP NEWS

WASHINGTON (AP) — U.S. regulators on Tuesday allowed emergency use of the first rapid coronavirus test that can be performed entirely at home and delivers results in 30 minutes.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA authorizes 1st rapid virus test that gives results at home
Log in or register to post comments

Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year

Wed, 2020-11-18 08:49 — mike kraft

Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Michael Erman U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer ends vaccine trial with 95% success rate, paving way for a shot this year
Log in or register to post comments

Covid testing before flying could become the norm as airlines try to boost confidence and woo travelers

Tue, 2020-11-17 11:56 — mike kraft

Covid testing before flying could become the norm as airlines try to boost confidence and woo travelers More than 100 countries already require proof of a negative coronavirus test for entry. Lori Aratani, Ian Duncan Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Vaccine Unproven? No Problem in China, Where People Scramble for Shots

Tue, 2020-11-17 11:29 — mike kraft

Vaccine unproven? No problem in China, where people scramble for shots China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines after a spate of quality scandals. Government officials and top pharmaceutical executives speak proudly of being inoculated. Sui-Lee Wee and Elsie Chen courant.com

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vaccine Unproven? No Problem in China, Where People Scramble for Shots
Log in or register to post comments

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states

Tue, 2020-11-17 11:16 — mike kraft

Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states Pfizer Inc <PFE.N> has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges facing its ultra-cold storage requirements. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer to start pilot delivery program for its COVID-19 vaccine in four U.S. states
Log in or register to post comments

Hospital-Acquired SARS-CoV-2 InfectionLessons for Public Health

Mon, 2020-11-16 20:23 — mike kraft

Hospital-Acquired SARS-CoV-2 Infection This Viewpoint reviews the rare incidence of nosocomial SARS-CoV-2 infection and discusses ways it can be minimized, including use of surgical masks, proper ventilation, physical distancing, eye protection, regular testing, and the availability of sick leave for health care workers. JAMA_current

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Hospital-Acquired SARS-CoV-2 InfectionLessons for Public Health
Log in or register to post comments

WHO tempers prospect of a coronavirus vaccine with warning of a long distribution fight to come

Mon, 2020-11-16 19:33 — mike kraft

WHO tempers prospect of a coronavirus vaccine with warning of a long fight to come Finding a coronavirus vaccine is like building a base camp on Mount Everest, not reaching the summit, the WHO says. Adam Taylor Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO tempers prospect of a coronavirus vaccine with warning of a long distribution fight to come
Log in or register to post comments

Pfizer vs Moderna vaccines: What we know, and what we don't

Mon, 2020-11-16 19:21 — mike kraft

Pfizer vs Moderna vaccines: What we know, and what we don't Two vaccine candidates using similar technology are winning the COVID-19 vaccine race in the U.S., and in the process validating the mRNA platform — which is yet untested on the market— as well as setting the path for vaccine makers to follow in order to block the virus. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Pfizer vs Moderna vaccines: What we know, and what we don't
Log in or register to post comments

Pages